Product Information
KURVELO-28 TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1135 per EA under NDC 68180084473. Its NADAC has been published 330 times since Jun 10, 2020.
FDA first approved this application on Oct 17, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180084473
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091408FDA Approved
10/17/2012
TE Code
AB
On Market Since
2/7/2021
Price Statistics
The NADAC for KURVELO-28 TABLET has been published 330 times since Jun 10, 2020, and over the history we have for it it has declined 60.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1135 per EA |
|---|---|
| All-time high | $0.2857 (Jun 10, 2020) |
| All-time low | $0.0800 (Nov 20, 2024) |
| 52-week high | $0.1210 |
| 52-week low | $0.1090 |
| Median price | $0.1511 |
| Average price | $0.1582 |
| Largest weekly change | +72.0% (Aug 21, 2024) |
| Weeks tracked | 330 |
| Tracking since | Jun 10, 2020 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levonorgestrel and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KURVELO-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KURVELO-28 TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1135 per EA (NDC 68180084473), effective Sep 30, 2026.
How has the price of KURVELO-28 TABLET changed over time?
Over the history we have for it, the NADAC for KURVELO-28 TABLET has declined 60.3%. It has been tracked across 330 weekly CMS publications since Jun 10, 2020.
What are the highest and lowest recorded NADAC prices for KURVELO-28 TABLET?
Since Jun 10, 2020, the NADAC for KURVELO-28 TABLET has ranged from a low of $0.0800 (Nov 20, 2024) to a high of $0.2857 (Jun 10, 2020), with a median of $0.1511 per EA.
Are there cheaper alternatives to KURVELO-28 TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVONOR-ETH ESTRAD 0.15-0.03, is $0.1128 per EA — about 1% below KURVELO-28 TABLET.
Who manufactures KURVELO-28 TABLET?
KURVELO-28 TABLET (NDC 68180084473) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.